CA Stock MarketDetailed Quotes

Hemostemix Inc (HEM)

Watchlist
  • 0.065
  • 0.0000.00%
15min DelayMarket Closed May 6 16:00 ET
12.25MMarket Cap-2.41P/E (TTM)

Hemostemix Inc (HEM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7,086.92%-2.91M
-1,266.54%-801.21K
380.41%337.47K
-33.98%-1.9M
-652.70%-1.81M
38.88%-40.43K
117.10%68.68K
83.08%-120.35K
76.73%-1.42M
72.55%-240.49K
Net income from continuing operations
-83.99%-578.75K
55.95%-228.76K
-170.13%-1.28M
-4.57%-2.62M
-91.19%-1.31M
-22.28%-314.56K
-82.26%-519.34K
62.74%-475.53K
52.21%-2.5M
49.27%-683.59K
Operating gains losses
----
----
----
----
----
----
----
-111.32%-4.24K
1.46%-178.62K
---331.71K
Depreciation and amortization
-56.00%11
-56.00%11
-52.00%12
-55.16%100
-55.36%25
-54.55%25
-55.36%25
-55.36%25
-54.95%223
-54.84%56
Remuneration paid in stock
11,409.63%476.84K
258.63%14.86K
13,116.27%547.55K
120.81%330.98K
117.06%318.55K
--4.14K
--4.14K
31.98%4.14K
-16.11%149.9K
2,985.77%146.76K
Deferred tax
----
----
----
----
----
----
----
----
--0
----
Other non cashItems
22.57%192.56K
15.36%172.85K
13.34%164.97K
10.63%615.21K
-30.47%162.71K
43.29%157.1K
34.93%149.84K
43.52%145.56K
57.09%556.12K
73.89%234.01K
Change In working capital
-1,876.13%-2M
-276.87%-760.17K
333.71%909.49K
-141.84%-232.11K
-349.86%-984.45K
272.33%112.86K
318.48%429.78K
-50.42%209.7K
132.53%554.73K
1,404.30%393.99K
-Change in receivables
3.11%18.06K
306.03%29.22K
5,690.15%160.1K
-279.62%-204.55K
-467.32%-226.39K
123.71%17.51K
-51.38%7.2K
-102.57%-2.86K
-44.11%113.88K
384.11%61.63K
-Change in prepaid assets
72.37%47.41K
84.46%-13.67K
-91.75%8.41K
34.09%76.63K
-66.01%35.18K
127.79%27.51K
-240.24%-87.95K
1,107.47%101.9K
130.04%57.15K
156.39%103.52K
-Change in payables and accrued expense
-3,151.14%-2.07M
-251.94%-775.72K
569.56%740.98K
-127.15%-104.19K
-446.64%-793.24K
-36.79%67.85K
286.17%510.54K
-65.61%110.67K
122.33%383.7K
16.14%228.84K
Cash from discontinued investing activities
Operating cash flow
-7,086.92%-2.91M
-1,266.54%-801.21K
380.41%337.47K
-33.98%-1.9M
-652.70%-1.81M
38.88%-40.43K
117.10%68.68K
83.08%-120.35K
76.73%-1.42M
72.55%-240.49K
Investing cash flow
Cash flow from continuing investing activities
0
0
-145.58K
0
0
0
Net investment purchase and sale
--0
--0
---145.58K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
---145.58K
----
----
--0
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
3.38M
515.05K
67.58K
70.38%2.45M
13,292.84%2.45M
0
0
0
-76.08%1.44M
18.31K
Net issuance payments of debt
----
----
----
----
----
----
----
----
--0
----
Net common stock issuance
--3.37M
----
----
71.91%2.45M
4,201.78%2.45M
--0
----
----
-58.67%1.43M
---59.79K
Proceeds from stock option exercised by employees
--13.68K
--32.89K
--67.58K
--0
--0
--0
--0
--0
-31.07%12.8K
--0
Net other financing activities
----
----
----
----
----
----
----
----
61.42%-78.1K
--0
Cash from discontinued financing activities
Financing cash flow
--3.38M
--515.05K
--67.58K
70.38%2.45M
13,292.84%2.45M
--0
--0
--0
-76.08%1.44M
--18.31K
Net cash flow
Beginning cash position
554.45%679.01K
2,652.19%965.16K
354.07%705.7K
14.49%155.42K
-83.23%63.33K
-32.77%103.75K
-87.12%35.07K
14.49%155.42K
-38.14%135.75K
-62.68%377.59K
Current changes in cash
1,281.69%477.7K
-516.64%-286.16K
315.60%259.46K
2,697.58%550.28K
389.13%642.37K
-118.11%-40.43K
158.20%68.68K
-188.10%-120.35K
123.50%19.67K
74.64%-222.17K
End cash Position
1,726.56%1.16M
554.45%679.01K
2,652.19%965.16K
354.07%705.7K
354.07%705.7K
-83.23%63.33K
-32.77%103.75K
-87.12%35.07K
14.49%155.42K
14.49%155.42K
Free cash from
-7,086.92%-2.91M
-1,266.54%-801.21K
380.41%337.47K
-33.98%-1.9M
-652.70%-1.81M
38.88%-40.43K
117.10%68.68K
83.08%-120.35K
76.73%-1.42M
72.55%-240.49K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7,086.92%-2.91M-1,266.54%-801.21K380.41%337.47K-33.98%-1.9M-652.70%-1.81M38.88%-40.43K117.10%68.68K83.08%-120.35K76.73%-1.42M72.55%-240.49K
Net income from continuing operations -83.99%-578.75K55.95%-228.76K-170.13%-1.28M-4.57%-2.62M-91.19%-1.31M-22.28%-314.56K-82.26%-519.34K62.74%-475.53K52.21%-2.5M49.27%-683.59K
Operating gains losses -----------------------------111.32%-4.24K1.46%-178.62K---331.71K
Depreciation and amortization -56.00%11-56.00%11-52.00%12-55.16%100-55.36%25-54.55%25-55.36%25-55.36%25-54.95%223-54.84%56
Remuneration paid in stock 11,409.63%476.84K258.63%14.86K13,116.27%547.55K120.81%330.98K117.06%318.55K--4.14K--4.14K31.98%4.14K-16.11%149.9K2,985.77%146.76K
Deferred tax ----------------------------------0----
Other non cashItems 22.57%192.56K15.36%172.85K13.34%164.97K10.63%615.21K-30.47%162.71K43.29%157.1K34.93%149.84K43.52%145.56K57.09%556.12K73.89%234.01K
Change In working capital -1,876.13%-2M-276.87%-760.17K333.71%909.49K-141.84%-232.11K-349.86%-984.45K272.33%112.86K318.48%429.78K-50.42%209.7K132.53%554.73K1,404.30%393.99K
-Change in receivables 3.11%18.06K306.03%29.22K5,690.15%160.1K-279.62%-204.55K-467.32%-226.39K123.71%17.51K-51.38%7.2K-102.57%-2.86K-44.11%113.88K384.11%61.63K
-Change in prepaid assets 72.37%47.41K84.46%-13.67K-91.75%8.41K34.09%76.63K-66.01%35.18K127.79%27.51K-240.24%-87.95K1,107.47%101.9K130.04%57.15K156.39%103.52K
-Change in payables and accrued expense -3,151.14%-2.07M-251.94%-775.72K569.56%740.98K-127.15%-104.19K-446.64%-793.24K-36.79%67.85K286.17%510.54K-65.61%110.67K122.33%383.7K16.14%228.84K
Cash from discontinued investing activities
Operating cash flow -7,086.92%-2.91M-1,266.54%-801.21K380.41%337.47K-33.98%-1.9M-652.70%-1.81M38.88%-40.43K117.10%68.68K83.08%-120.35K76.73%-1.42M72.55%-240.49K
Investing cash flow
Cash flow from continuing investing activities 00-145.58K000
Net investment purchase and sale --0--0---145.58K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow --0--0---145.58K----------0--0--0--------
Financing cash flow
Cash flow from continuing financing activities 3.38M515.05K67.58K70.38%2.45M13,292.84%2.45M000-76.08%1.44M18.31K
Net issuance payments of debt ----------------------------------0----
Net common stock issuance --3.37M--------71.91%2.45M4,201.78%2.45M--0---------58.67%1.43M---59.79K
Proceeds from stock option exercised by employees --13.68K--32.89K--67.58K--0--0--0--0--0-31.07%12.8K--0
Net other financing activities --------------------------------61.42%-78.1K--0
Cash from discontinued financing activities
Financing cash flow --3.38M--515.05K--67.58K70.38%2.45M13,292.84%2.45M--0--0--0-76.08%1.44M--18.31K
Net cash flow
Beginning cash position 554.45%679.01K2,652.19%965.16K354.07%705.7K14.49%155.42K-83.23%63.33K-32.77%103.75K-87.12%35.07K14.49%155.42K-38.14%135.75K-62.68%377.59K
Current changes in cash 1,281.69%477.7K-516.64%-286.16K315.60%259.46K2,697.58%550.28K389.13%642.37K-118.11%-40.43K158.20%68.68K-188.10%-120.35K123.50%19.67K74.64%-222.17K
End cash Position 1,726.56%1.16M554.45%679.01K2,652.19%965.16K354.07%705.7K354.07%705.7K-83.23%63.33K-32.77%103.75K-87.12%35.07K14.49%155.42K14.49%155.42K
Free cash from -7,086.92%-2.91M-1,266.54%-801.21K380.41%337.47K-33.98%-1.9M-652.70%-1.81M38.88%-40.43K117.10%68.68K83.08%-120.35K76.73%-1.42M72.55%-240.49K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More